Compliance: Difference between revisions

16 bytes added ,  September 26, 2013
no edit summary
No edit summary
No edit summary
Line 21: Line 21:
== [[Investigations by Third Parties]] ==
== [[Investigations by Third Parties]] ==
== [[Research Integrity]] ==
== [[Research Integrity]] ==
== Copyright ==
== [[Copyright]] ==
== Export Control ==
== [[Export Control]] ==
== [[Code of Conduct]] ==
== [[Code of Conduct]] ==
== [[Use of Human Anatomical Material]] ==
== [[Use of Human Anatomical Material]] ==
== [[Clinical Trial Fee Billing Procedures]] ==
== [[Clinical Trial Fee Billing Procedures]] ==
== [[Contracts]] ==
== [[Contracts]] ==
== [[Business Associate Agreements and Addendum Procedures]] ==
=== [[Business Associate Agreements and Addendum Procedures]] ===
== [[Conflict of Interest]] ==
== [[Conflict of Interest]] ==
== [[Conflict of Interest Procedures]] ==
=== [[Conflict of Interest Procedures]] ===
== [[Research Conflict of Interest Procedures]] ==
=== [[Research Conflict of Interest Procedures]] ===
== [[Conflict of Interest Committee]] ==
=== [[Conflict of Interest Committee]] ===
== [[Red Flag Identity Theft Prevention Program]] ==
== [[Red Flag Identity Theft Prevention Program]] ==
== [[Principles of Financial Stewardship]] ==
== [[Principles of Financial Stewardship]] ==
== [[Human Tissue Use & Transfer]] ==
== [[Human Tissue Use & Transfer]] ==